Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX)

21 filings reported holding ELTX - Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share as of Q3 2024.
Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 491,473 shares of 16,785,250 outstanding shares and own 2.93% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (245,262 shares), GEODE CAPITAL MANAGEMENT, LLC (71,574 shares), CM Management, LLC (50,000 shares), NORTHERN TRUST CORP (30,769 shares), STATE STREET CORP (21,900 shares), BlackRock, Inc. (19,693 shares), MEYER HANDELMAN CO (13,899 shares), CITADEL ADVISORS LLC (12,856 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (12,500 shares), and CIBC Private Wealth Group LLC (7,000 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.